Poliquistosis renal autosómica dominante: un factor de riesgo cardiovascular
González Martínez, Miguel Ángel; Hernández García, Elena; Morales García, Ana Isabel.
Med. clín (Ed. impr.)
; 161(6): 271-272, sept. 2023. tab
Artículo en Español | IBECS (España) | ID: ibc-225552
Documentos relacionados
Factors Associated With the Development and Severity of Polycystic Liver in Patients With Autosomal Dominant Polycystic Kidney Disease.
The screening, diagnosis, and management of patients with autosomal dominant polycystic kidney disease: A national consensus statement from Taiwan.
Vascular complications in autosomal dominant polycystic kidney disease.
Association of autosomal dominant polycystic kidney disease with cardiovascular disease: a US-National Inpatient Perspective.
Current recommendations for treating autosomal dominant polycystic kidney disease.
Renin-angiotensin system activation: may it increase frequency of obstructive sleep apnea in patients with autosomal dominant polycystic kidney disease?
Clinical findings, underlying pathogenetic processes and treatment of vascular dysfunction in autosomal dominant polycystic kidney disease.
Individualized Nutritional Prescription Is Necessary for Patients With Autosomal Dominant Polycystic Kidney Disease.
Nephrotic syndrome in autosomal dominant polycystic kidney disease in children versus adults: Answers.
Should we screen for intracranial aneurysms in children with autosomal dominant polycystic kidney disease?